26 Nov

Change of Directors Interest Notice

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001. Name of entity EVE Investments Limited to be renamed EVE Health Group Limited ABN 89 106 523 611 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Gregory William Fry Date of last notice 26 November 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. The Fry Family Superfund Abigail Fry (spouse) Date of change 24-25 November 2021 No. of securities held prior to change Direct 61,247,888 Ordinary Shares 18,000,000 Performance Rights 3,333,332 Unlisted options exercisable at $0.006 by 31 December 2021 16,000,000 Unlisted option s exercisable at $0.0 1 6 by 26 November 2024 Indirect 14,654,734 Ordinary Shares Class Ordinary Shares Number acquired 1,787,235 Ordinary Shares (Super F und) Transfer from direct to indirect: 45,760,124 Ordinary Shares (Abigail Fry) 13,133,332 Ordinary Shares (Super Fund) Number disposed Transfer from direct to indirect: 58,893,456 Ordinary Shares Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $7,149 No. of securities held after change Direct 4,141,667 Ordinary Shares 18,000,000 Performance Rights 3,333,332 Unlisted options exercisable at $0.006 by 31 December 2021 16,000,000 Unlisted option s exercisable at $0.0 1 6 by 26 November 2024 Appendix 3Y Change of Director’s Interest Notice Appendix 3Y Page 2 Indirect 27,788,066 Ordinary Shares (Super Fund) 45,760,124 Ordinary Shares (Abigail Fry) Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back On market acquisitions / transfer from direct to indirect holding Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Eve Health Group Limited (ASX:EVE) when you join Listcorp.